α-Bisabolol, a nontoxic natural compound, strongly induces apoptosis in glioma cells

Biochemical and Biophysical Research Communications

Volumn 315, Issue 3, 2004, Pages 589-594

  Cavalieri, Elisabetta ^a   Mariotto, Sofia ^a   Fabrizi, Cinzia ^b   De Prati, Alessandra Carcereri ^a   Gottardo, Rossella ^a   Leone, Stefano ^b   Berra, Luigi Valentino ^a   Lauro, Giuliana Maria ^b   Ciampa, Anna Rosa ^a   Suzuki, Hisanori ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b ROMA TRE UNIVERSITY   (Italy)

Author keywords

Apoptosis; Chemotherapy; Glioma; Human; Bisabolol

Indexed keywords

ANTINEOPLASTIC AGENT; BISABOLOL; CYTOCHROME C; DNA; NATURAL PRODUCT; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; SESQUITERPENE DERIVATIVE;

ANIMAL CELL; APOPTOSIS; ARTICLE; BIOACCUMULATION; CANCER GROWTH; CANCER INHIBITION; CELL DEATH; CELL SURVIVAL; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; ENZYME DEGRADATION; ENZYME RELEASE; GLIA CELL; GLIOMA CELL; HUMAN; HUMAN CELL; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 10744228702     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.01.088     Document Type: Article

References (21)

1. De Angelis L.M. Brain tumors. N. Engl. J. Med. 344:2001;114-123.
2. Parker S.L., Tong T., Bolden S., Wingo P.A. Cancer statistics. CA Cancer J. Clin. 46:1996;5-27.
3. Kornblith P.L., Walker M. Chemotherapy for malignant gliomas. J. Neurosurg. 68:1988;1-17.
4. Surawicz T.S., Davis F., Freels S., Laws E.R. Jr., Menck H.R. Brain tumor survival: results from the national cancer data base. J. Neurooncol. 40:1998;151-160.
5. Rosenblum M.L., Gerosa M.A., Dougherty D.V., Wilson C.B. Improved treatment of a brain-tumor model. J. Neurosurg. 58:1983;177-182.
6. Fulda S., Jeremias I., Steiner H.H., Pietsch T., Debatin K.M. Betulinic acid: a new cytotoxic agent against malignant brain-tumor cells. Int. J. Cancer. 82:1999;435-441.
7. 2+ release and enhanced expression of p53 in HepG2 human hepatoma cells. Cancer Lett. 186:2002;83-91.
8. Jakovlev V., Von Schlichtegroll A. On the inflammation inhibitory effect of (-)-alpha-bisabolol, an essential component of chamomilla oil. Arzneimittelforschung. 19:1969;615-616.
9. Jakovlev V., Isaac O., Thiemer K., Kunde R. Pharmacological investigations with compounds of chamomile ii. New investigations on the antiphlogistic effects of (-)-alpha-bisabolol and bisabolol oxides (author's transl.). Planta Med. 35:1979;125-140.
10. Budavari S. The Merk Index. twelfth ed. 1996;208-209 Merck Research Laboratories Division of Merck & Co., Inc.
11. Hernandez-Ceruelos A., Madrigal-Bujaidar E., De LaCruz C. Inhibitory effect of chamomile essential oil on the sister chromatid exchanges induced by daunorubicin and methyl methanesulfonate in mouse bone marrow. Toxicol. Lett. 135:2002;103-110.
12. Villegas L.F., Marcalo A., Martin J., Fernandez I.D., Maldonado H., Vaisberg A.J., Hammond G.B. (+)-epi-Alpha-bisabolol [correction of bisabolol] is the wound-healing principle of Peperomia galioides: investigation of the in vivo wound-healing activity of related terpenoids. J. Nat. Prod. 64:2001;1357-1359.
13. Lauro G.M., Di Lorenzo N., Grossi M., Maleci A., Guidetti B. Prostaglandin E2 as an immunomodulating factor released in vitro by human glioma cells. Acta Neuropathol. (Berl). 69:1986;278-282.
14. Hansen M.B., Nielsen S.E., Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods. 119:1989;203-210.
15. Smiley S.T., Reers M., Mottola-Hartshorn C., Lin M., Chen A., Smith T., Steele G.D., Chen L. Intracellular heterogeneity in mitochondrial membrane potentials revealed by J-aggregate-forming lipophilic cation JC-1. Proc. Natl. Acad. Sci. USA. 88:1991;3671-3675.
16. Yung W.K. In vitro chemosensitivity testing and its clinical application in human gliomas. Neurosurg. Rev. 12:1989;197-203.
17. Kerr J.F.R., Harmon B.V. Definition and incidence of apoptosis: an historical perspective. Tomei L.D., Cope F.O. Apoptosis: The Molecular Basis of Cell Death. 1991;5-31 Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
18. Snider B.J., Gottron J.F., Choi D.W. Apoptosis and necrosis in cerebrovascular disease. Ann. N Y Acad. Sci. 893:1999;243-253.
19. Geske F.J., Gerschenson L.E. The biology of apoptosis. Hum. Pathol. 32:2001;1029-1038.
20. Kaufmann S.H., Earnshaw W.C. Induction of apoptosis by cancer chemotherapy. Exp. Cell Res. 256:2000;42-49.
21. Zamzami N., Marchetti P., Castedo M., Hirsch T., Susin S.A., Masse B., Kroemer G. Inhibitors of permeability transition interfere with the disruption of the mitochondrial transmembrane potential during apoptosis. FEBS Lett. 384:1996;53-57.